137 related articles for article (PubMed ID: 15506973)
1. Post-translational modification of RelA(p65) NF-kappaB.
Campbell KJ; Perkins ND
Biochem Soc Trans; 2004 Dec; 32(Pt 6):1087-9. PubMed ID: 15506973
[TBL] [Abstract][Full Text] [Related]
2. Regulation and function of IKK and IKK-related kinases.
Häcker H; Karin M
Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
[TBL] [Abstract][Full Text] [Related]
3. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
[TBL] [Abstract][Full Text] [Related]
4. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
Manna SK; Gangadharan C
Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
[TBL] [Abstract][Full Text] [Related]
5. Zn2+-induced NF-kappaB-dependent transcriptional activity involves site-specific p65/RelA phosphorylation.
Kim YM; Cao D; Reed W; Wu W; Jaspers I; Tal T; Bromberg PA; Samet JM
Cell Signal; 2007 Mar; 19(3):538-46. PubMed ID: 17008051
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
[TBL] [Abstract][Full Text] [Related]
7. Impact of post-translational modifications of proteins on the inflammatory process.
Ito K
Biochem Soc Trans; 2007 Apr; 35(Pt 2):281-3. PubMed ID: 17371260
[TBL] [Abstract][Full Text] [Related]
8. 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB.
Tse AK; Wan CK; Shen XL; Zhu GY; Cheung HY; Yang M; Fong WF
Exp Cell Res; 2007 May; 313(8):1722-34. PubMed ID: 17397830
[TBL] [Abstract][Full Text] [Related]
9. Regulation of NF-kappaB transcriptional activity.
Vermeulen L; Vanden Berghe W; Haegeman G
Cancer Treat Res; 2006; 130():89-102. PubMed ID: 16610704
[TBL] [Abstract][Full Text] [Related]
10. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway.
Perkins ND
Oncogene; 2006 Oct; 25(51):6717-30. PubMed ID: 17072324
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.
Viatour P; Merville MP; Bours V; Chariot A
Trends Biochem Sci; 2005 Jan; 30(1):43-52. PubMed ID: 15653325
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB: a multifaceted transcription factor regulated at several levels.
Schmitz ML; Mattioli I; Buss H; Kracht M
Chembiochem; 2004 Oct; 5(10):1348-58. PubMed ID: 15457532
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
Hu J; Colburn NH
Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
[TBL] [Abstract][Full Text] [Related]
14. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
15. Regulating the regulator: NF-kappaB signaling in heart.
Hall G; Hasday JD; Rogers TB
J Mol Cell Cardiol; 2006 Oct; 41(4):580-91. PubMed ID: 16949095
[TBL] [Abstract][Full Text] [Related]
16. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation.
Campbell KJ; Witty JM; Rocha S; Perkins ND
Cancer Res; 2006 Jan; 66(2):929-35. PubMed ID: 16424027
[TBL] [Abstract][Full Text] [Related]
18. Assessing acetylation of NF-kappaB.
Chen LF; Greene WC
Methods; 2005 Aug; 36(4):368-75. PubMed ID: 16111893
[TBL] [Abstract][Full Text] [Related]
19. N-tosyl-L-phenylalanine chloromethyl ketone inhibits NF-kappaB activation by blocking specific cysteine residues of IkappaB kinase beta and p65/RelA.
Ha KH; Byun MS; Choi J; Jeong J; Lee KJ; Jue DM
Biochemistry; 2009 Aug; 48(30):7271-8. PubMed ID: 19591457
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of transcription factor NF-kappaB signaling proteins IKKbeta and p65 through specific cysteine residues by epoxyquinone A monomer: correlation with its anti-cancer cell growth activity.
Liang MC; Bardhan S; Pace EA; Rosman D; Beutler JA; Porco JA; Gilmore TD
Biochem Pharmacol; 2006 Feb; 71(5):634-45. PubMed ID: 16360644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
